LATS2 and cancer: Moreover, we found an exogenous factor (unknown autocrine soluble factor) that reduces the protein level of LATS2 in heterogeneous SAS-δ cells, and in the future we aim to establish that this is associated with an increased risk of malignancy for the heterogeneous population of cancer cells as a cancer microenvironment using this experimental system with SAS-δ.